Minerva Surgical Inc (UTRS)
0.001
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
Minerva Surgical Free Cash Flow (Quarterly): -5.112M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -5.112M |
June 30, 2023 | -9.621M |
March 31, 2023 | -8.461M |
December 31, 2022 | -15.59M |
September 30, 2022 | -6.805M |
June 30, 2022 | -5.536M |
Date | Value |
---|---|
March 31, 2022 | -7.707M |
December 31, 2021 | -10.77M |
September 30, 2021 | -5.526M |
June 30, 2021 | -3.346M |
March 31, 2021 | -3.322M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-15.59M
Minimum
Dec 2022
-3.322M
Maximum
Mar 2021
-7.436M
Average
-6.805M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
Viveve Medical Inc | -- |
HTG Molecular Diagnostics Inc | -- |
Stereotaxis Inc | -2.346M |
Electromed Inc | 1.222M |
Myomo Inc | -3.305M |